CHICAGO -- A series of large, real-world analyses supported benefit of GLP-1 receptor agonists in cardiopulmonary indications for patients with type 2 diabetes, researchers reported at the CHEST ...

For decades, scientists have thought they understood the biochemical machinery that causes asthma—inflammation in the lungs that constricts airways and makes it hard to breathe.

Ethical and statistical power issues limit the use of randomized controlled trials to study medication and vaccine use during ...

CHICAGO -- A fixed-dose inhaler combining an inhaled corticosteroid, long-acting muscarinic antagonist, and long-acting beta ...

Patients treated for uncontrolled mild asthma had high symptom burden affecting their daily life but most had no ...

Cole Schmidtknecht's family says Walgreens and OptumRx are liable for his death, which occurred after he couldn't afford an ...

Chiesi USA's asthma inhaler could simplify treatment for millions of Americans. Triangle Forward: What's Next for Life Sciences?

The new tool, available as a phone app, helps identify comorbidities and produces a score to guide clinicians.

C HICAGO -- Adverse event risks varied across biologics used by asthma patients, an analysis of data submitted to the FDA ...

The FDA accepted a new drug application for a single inhaler that contains beclomethasone dipropionate, formoterol fumarate ...

The FDA has accepted for review the NDA for Chiesi’s single inhaler triple therapy for the maintenance treatment of asthma in adults.

The FDA has accepted for review Chiesi’s New Drug Application (NDA) for their investigational maintenance treatment for ...